dr. galsky discusses neoadjuvant immunotherapy in bladder cancer
Published 5 years ago • 89 plays • Length 1:36Download video MP4
Download video MP3
Similar videos
-
1:58
dr. galsky discusses combination immunotherapy in bladder cancer
-
0:59
dr. galsky on progression on immunotherapy in bladder cancer
-
1:35
dr. galsky on neoadjuvant immune checkpoint blockade in bladder cancer
-
2:19
dr. galsky discusses the rationale for the imvigor130 study in bladder cancer
-
8:21
introduction: neoadjuvant chemotherapy in bladder cancer
-
2:25
dr. galsky discusses progression in patients with metastatic bladder cancer
-
0:59
dr. galsky on resistance to checkpoint blockade in metastatic bladder cancer
-
1:24
dr. sonpavde on neoadjuvant immunotherapy in bladder cancer
-
1:09
dr. galsky on the role of ipilimumab in bladder cancer
-
1:03
dr. inman discusses the biology of bladder cancer
-
2:03
dr. galsky on targeted therapies in bladder cancer
-
1:07
dr. galsky on ipilimumab in bladder cancer
-
1:35
matthew galsky gives an overview of bladder cancer
-
44:28
breakthroughs in bladder cancer immunotherapy, with matthew galsky
-
2:21
dr. galsky on maintenance pembrolizumab in urothelial cancer
-
1:20
dr. galsky on the role of ipilimumab for the treatment of bladder cancer
-
1:10
dr. sonpavde on the potential for neoadjuvant immunotherapy in bladder cancer
-
0:57
the possibility for immunotherapy in neoadjuvant bladder cancer treatment
-
1:40
matthew galsky discusses treatment for lymph node-positive bladder cancer